Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Venous Thrombosis III: Interprofessional Care

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...

Vascular Spasm

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spatial and Functional Immune Profiling Identifies Impaired Vascular Repair in Human Myocardial Infarction.

Biomedicines·2026

Same author

Development of a Novel Risk Assessment Scale to Improve the Consistency and Reliability of Risk-Based Approaches in Clinical Trials.

Therapeutic innovation & regulatory science·2026

Same author

Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan　- Insights From the PARACLETE Study.

Circulation journal : official journal of the Japanese Circulation Society·2026

Same author

Long-term safety and efficacy of filgotinib in patients with idiopathic multicentric Castleman disease: 52-week results from a Phase Ib clinical trial.

Modern rheumatology·2026

Same author

First-in-human study to investigate the safety and efficacy of effective-mononuclear cell therapy for radiogenic xerostomia.

Regenerative therapy·2026

Same author

Prevalence, Characteristics, and Pharmacological Strategies in Patients With Heart Failure With Supranormal Ejection Fraction　- Insights From the PARACLETE Study.

Circulation journal : official journal of the Japanese Circulation Society·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

[Vascular regeneration therapy for intractable vasculitis].

Atsuhiko Kawamoto¹, Takayuki Asahara

¹Division of Vascular Regeneration Therapy, Department of Regeneration Medicine, Institute of Biomedical Research and Innovation.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|March 14, 2009

Summary

Endothelial progenitor cells (EPCs) are crucial for vascular regeneration and show promise in cardiovascular therapies. Their dysfunction indicates poor prognosis, but transplantation strategies are advancing for conditions like coronary artery disease.

More Related Videos

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts

Published on: September 10, 2018

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Published on: March 4, 2016

Related Experiment Videos

Last Updated: Jun 24, 2026

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Assessment of Vascular Regeneration in the CNS Using the Mouse Retina

Published on: June 23, 2014

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts

A Rabbit Model of Durable Transgene Expression in Jugular Vein to Common Carotid Artery Interposition Grafts

Published on: September 10, 2018

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Intraluminal Drug Delivery to the Mouse Arteriovenous Fistula Endothelium

Published on: March 4, 2016

Area of Science:

Cardiovascular research
Regenerative medicine
Cell biology

Context:

Cell-based transplantation is emerging as a significant cardiovascular therapy.
Endothelial progenitor cells (EPCs) are key players in vascular repair and regeneration.
EPC dysfunction is linked to cardiovascular diseases and poor prognosis.

Purpose:

To review the role of endothelial progenitor cells (EPCs) in cardiovascular health and disease.
To discuss the therapeutic potential of EPC transplantation for ischemic conditions.
To highlight advancements in EPC processing and clinical trial progress.

Summary:

Endothelial progenitor cells (EPCs), primarily from bone marrow, differentiate into endothelial cells and contribute to vascular regeneration.
Reduced EPC number and function are observed in patients with diabetes, coronary artery disease (CAD), and other risk factors.
Preclinical and early clinical studies demonstrate the safety and feasibility of EPC transplantation for various ischemic diseases, including CAD.

Impact:

EPC transplantation holds significant potential for treating cardiovascular diseases.
Further development in cell processing technologies will enhance the efficacy of EPC-based therapies.
Advancements are paving the way for widespread clinical application of EPC transplantation in cardiovascular medicine.